# Freeport-Mcmoran Inc: financial statements, quarterly

FCX · NYSE · CIK 831259 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcx.md) · [Financials](/companies/fcx/financials.md) · [Filings](/companies/fcx/filings.md) · [Insiders](/companies/fcx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,864](/filings/0000831259-24-000039.md) | [5,796 d](/filings/0000831259-26-000012.md) | [6,211](/filings/0000831259-25-000018.md) | [6,398](/filings/0000831259-25-000031.md) | [6,680](/filings/0000831259-25-000050.md) | [5,880 d](/filings/0000831259-26-000012.md) | [5,574](/filings/0000831259-26-000025.md) | [7,526](/filings/0000831259-26-000036.md) | [6,819](/filings/0000831259-25-000050.md) | [5,267 d](/filings/0000831259-26-000012.md) | [6,254](/filings/0000831259-26-000025.md) | [6,917](/filings/0000831259-26-000036.md) |
| Cost of revenue | $m | [4,086](/filings/0000831259-24-000039.md) | [3,949 d](/filings/0000831259-26-000012.md) | [4,439](/filings/0000831259-25-000018.md) | [4,384](/filings/0000831259-25-000031.md) | [4,677](/filings/0000831259-25-000050.md) | [4,295 d](/filings/0000831259-26-000012.md) | [4,222](/filings/0000831259-26-000025.md) | [4,950](/filings/0000831259-26-000036.md) | [4,830](/filings/0000831259-25-000050.md) | [4,616 d](/filings/0000831259-26-000012.md) | [4,579](/filings/0000831259-26-000025.md) | [4,843](/filings/0000831259-26-000036.md) |
| Selling, general and administrative | $m | [118](/filings/0000831259-24-000039.md) | [120 d](/filings/0000831259-26-000012.md) | [144](/filings/0000831259-25-000018.md) | [123](/filings/0000831259-25-000031.md) | [117](/filings/0000831259-25-000050.md) | [129 d](/filings/0000831259-26-000012.md) | [154](/filings/0000831259-26-000025.md) | [127](/filings/0000831259-26-000036.md) | [131](/filings/0000831259-25-000050.md) | [133 d](/filings/0000831259-26-000012.md) | [162](/filings/0000831259-26-000025.md) | [135](/filings/0000831259-26-000036.md) |
| Operating income | $m | [1,492](/filings/0000831259-24-000039.md) | [1,722 d](/filings/0000831259-26-000012.md) | [1,634](/filings/0000831259-25-000018.md) | [2,049](/filings/0000831259-25-000031.md) | [1,938](/filings/0000831259-25-000050.md) | [1,243 d](/filings/0000831259-26-000012.md) | [1,303](/filings/0000831259-26-000025.md) | [2,432](/filings/0000831259-26-000036.md) | [1,972](/filings/0000831259-25-000050.md) | [811 d](/filings/0000831259-26-000012.md) | [2,137](/filings/0000831259-26-000025.md) | [2,003](/filings/0000831259-26-000036.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [508](/filings/0000831259-24-000039.md) | [724 d](/filings/0000831259-26-000012.md) | [512](/filings/0000831259-25-000018.md) | [754](/filings/0000831259-25-000031.md) | [737](/filings/0000831259-25-000050.md) | [520 d](/filings/0000831259-26-000012.md) | [500](/filings/0000831259-26-000025.md) | [850](/filings/0000831259-26-000036.md) | [669](/filings/0000831259-25-000050.md) | [202 d](/filings/0000831259-26-000012.md) | [653](/filings/0000831259-26-000025.md) | [544](/filings/0000831259-26-000036.md) |
| Net income | $m | [964](/filings/0000831259-24-000039.md) | [1,007 d](/filings/0000831259-26-000012.md) | [1,162](/filings/0000831259-25-000018.md) | [1,280](/filings/0000831259-25-000031.md) | [1,236](/filings/0000831259-25-000050.md) | [721 d](/filings/0000831259-26-000012.md) | [793](/filings/0000831259-26-000025.md) | [772](/filings/0000831259-26-000036.md) | [1,247](/filings/0000831259-25-000050.md) | [565 d](/filings/0000831259-26-000012.md) | [1,387](/filings/0000831259-26-000025.md) | [984](/filings/0000831259-26-000036.md) |
| Diluted EPS | $ per share | [0.31](/filings/0000831259-24-000039.md) | not reported | [0.32](/filings/0000831259-25-000018.md) | [0.42](/filings/0000831259-25-000031.md) | [0.36](/filings/0000831259-25-000050.md) | not reported | [0.24](/filings/0000831259-26-000025.md) | [0.53](/filings/0000831259-26-000036.md) | [0.46](/filings/0000831259-25-000050.md) | not reported | [0.61](/filings/0000831259-26-000025.md) | [0.68](/filings/0000831259-26-000036.md) |
| Basic EPS | $ per share | [0.31](/filings/0000831259-24-000039.md) | not reported | [0.33](/filings/0000831259-25-000018.md) | [0.42](/filings/0000831259-25-000031.md) | [0.36](/filings/0000831259-25-000050.md) | not reported | [0.24](/filings/0000831259-26-000025.md) | [0.53](/filings/0000831259-26-000036.md) | [0.46](/filings/0000831259-25-000050.md) | not reported | [0.61](/filings/0000831259-26-000025.md) | [0.68](/filings/0000831259-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [5.7](/filings/0000831259-23-000037.md) | [4.8](/filings/0000831259-25-000006.md) | [5.2](/filings/0000831259-24-000019.md) | [5.3](/filings/0000831259-24-000031.md) | [5.0](/filings/0000831259-24-000039.md) | [3.9](/filings/0000831259-26-000012.md) | [4.4](/filings/0000831259-25-000018.md) | [4.5](/filings/0000831259-25-000031.md) | [4.3](/filings/0000831259-25-000050.md) | [3.8](/filings/0000831259-26-000036.md) | [3.7](/filings/0000831259-26-000025.md) | [4.1](/filings/0000831259-26-000036.md) |
| Current assets | $bn | [14.1](/filings/0000831259-23-000037.md) | [14.1](/filings/0000831259-25-000006.md) | [14.8](/filings/0000831259-24-000019.md) | [14.7](/filings/0000831259-24-000031.md) | [14.5](/filings/0000831259-24-000039.md) | [13.3](/filings/0000831259-26-000012.md) | [13.8](/filings/0000831259-25-000018.md) | [13.6](/filings/0000831259-25-000031.md) | [13.6](/filings/0000831259-25-000050.md) | [13.8](/filings/0000831259-26-000036.md) | [14.1](/filings/0000831259-26-000025.md) | [14.2](/filings/0000831259-26-000036.md) |
| Total assets | $bn | [51.6](/filings/0000831259-24-000039.md) | [52.5](/filings/0000831259-26-000012.md) | [54.2](/filings/0000831259-25-000018.md) | [54.6](/filings/0000831259-25-000031.md) | [55.4](/filings/0000831259-25-000050.md) | [54.8](/filings/0000831259-26-000012.md) | [56.0](/filings/0000831259-26-000025.md) | [56.5](/filings/0000831259-26-000036.md) | [56.8](/filings/0000831259-25-000050.md) | [58.2](/filings/0000831259-26-000036.md) | [58.8](/filings/0000831259-26-000025.md) | [59.7](/filings/0000831259-26-000036.md) |
| Current liabilities | $bn | [4.9](/filings/0000831259-23-000037.md) | [5.8](/filings/0000831259-25-000006.md) | [6.3](/filings/0000831259-24-000019.md) | [6.1](/filings/0000831259-24-000031.md) | [6.2](/filings/0000831259-24-000039.md) | [5.5](/filings/0000831259-26-000012.md) | [5.9](/filings/0000831259-25-000018.md) | [5.5](/filings/0000831259-25-000031.md) | [5.5](/filings/0000831259-25-000050.md) | [6.0](/filings/0000831259-26-000036.md) | [5.9](/filings/0000831259-26-000025.md) | [6.9](/filings/0000831259-26-000036.md) |
| Total liabilities | $bn | [25.0](/filings/0000831259-23-000037.md) | [25.2](/filings/0000831259-25-000006.md) | [26.1](/filings/0000831259-24-000019.md) | [25.9](/filings/0000831259-24-000031.md) | [26.5](/filings/0000831259-24-000039.md) | [26.1](/filings/0000831259-26-000012.md) | [26.8](/filings/0000831259-25-000018.md) | [26.5](/filings/0000831259-25-000031.md) | [26.4](/filings/0000831259-25-000050.md) | [27.4](/filings/0000831259-26-000036.md) | [27.3](/filings/0000831259-26-000025.md) | [27.5](/filings/0000831259-26-000036.md) |
| Long-term debt | $bn | [9.4](/filings/0000831259-23-000037.md) | [8.7](/filings/0000831259-25-000006.md) | [8.7](/filings/0000831259-24-000019.md) | [8.7](/filings/0000831259-24-000031.md) | [8.9](/filings/0000831259-24-000039.md) | [8.9](/filings/0000831259-26-000012.md) | [8.9](/filings/0000831259-25-000018.md) | [8.9](/filings/0000831259-25-000031.md) | [8.9](/filings/0000831259-25-000050.md) | [8.9](/filings/0000831259-26-000036.md) | [8.9](/filings/0000831259-26-000025.md) | [8.2](/filings/0000831259-26-000036.md) |
| Current portion of debt | $bn | [0.0](/filings/0000831259-23-000037.md) | [0.8](/filings/0000831259-25-000006.md) | [0.8](/filings/0000831259-24-000019.md) | [0.8](/filings/0000831259-24-000031.md) | [0.8](/filings/0000831259-24-000039.md) | [0.0](/filings/0000831259-26-000012.md) | [0.5](/filings/0000831259-25-000018.md) | [0.3](/filings/0000831259-25-000031.md) | [0.4](/filings/0000831259-25-000050.md) | [0.5](/filings/0000831259-26-000036.md) | [0.5](/filings/0000831259-26-000025.md) | [1.2](/filings/0000831259-26-000036.md) |
| Shareholders' equity | $bn | [16.5](/filings/0000831259-23-000037.md) | [16.7](/filings/0000831259-25-000006.md) | [17.0](/filings/0000831259-24-000019.md) | [17.4](/filings/0000831259-24-000031.md) | [17.5](/filings/0000831259-24-000039.md) | [17.6](/filings/0000831259-26-000012.md) | [17.7](/filings/0000831259-25-000018.md) | [18.2](/filings/0000831259-25-000031.md) | [18.7](/filings/0000831259-25-000050.md) | [18.9](/filings/0000831259-26-000036.md) | [19.5](/filings/0000831259-26-000025.md) | [20.1](/filings/0000831259-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,236 d](/filings/0000831259-24-000039.md) | [1,320 d](/filings/0000831259-26-000012.md) | [1,896](/filings/0000831259-25-000018.md) | [1,956 d](/filings/0000831259-25-000031.md) | [1,872 d](/filings/0000831259-25-000050.md) | [1,436 d](/filings/0000831259-26-000012.md) | [1,058](/filings/0000831259-26-000025.md) | [2,195 d](/filings/0000831259-26-000036.md) | [1,664 d](/filings/0000831259-25-000050.md) | [693 d](/filings/0000831259-26-000012.md) | [1,495](/filings/0000831259-26-000025.md) | [2,048 d](/filings/0000831259-26-000036.md) |
| Capital expenditure | $m | [1,178](/filings/0000831259-24-000039.md) | [1,362 d](/filings/0000831259-26-000012.md) | [1,254](/filings/0000831259-25-000018.md) | [1,116](/filings/0000831259-25-000031.md) | [1,199](/filings/0000831259-25-000050.md) | [1,239 d](/filings/0000831259-26-000012.md) | [1,172](/filings/0000831259-26-000025.md) | [1,261](/filings/0000831259-25-000031.md) | [1,056](/filings/0000831259-25-000050.md) | [1,005 d](/filings/0000831259-26-000012.md) | [973](/filings/0000831259-26-000025.md) | not reported |
| Dividends paid | $m | [215 d](/filings/0000831259-24-000039.md) | [216 d](/filings/0000831259-26-000012.md) | [218](/filings/0000831259-25-000018.md) | [215 d](/filings/0000831259-25-000031.md) | [216 d](/filings/0000831259-25-000050.md) | [216 d](/filings/0000831259-26-000012.md) | [218](/filings/0000831259-26-000025.md) | [215 d](/filings/0000831259-26-000036.md) | [216 d](/filings/0000831259-25-000050.md) | [216 d](/filings/0000831259-26-000012.md) | [218](/filings/0000831259-26-000025.md) | [216 d](/filings/0000831259-26-000036.md) |
| Share repurchases | $m | [0.0 d](/filings/0000831259-24-000039.md) | [0.0 d](/filings/0000831259-26-000012.md) | [0.0](/filings/0000831259-25-000018.md) | [0.0 d](/filings/0000831259-25-000031.md) | [59.0 d](/filings/0000831259-25-000050.md) | [0.0 d](/filings/0000831259-26-000012.md) | [55.0](/filings/0000831259-26-000025.md) | [52.0 d](/filings/0000831259-26-000036.md) | [0.0 d](/filings/0000831259-25-000050.md) | [0.0 d](/filings/0000831259-26-000012.md) | [93.0](/filings/0000831259-26-000025.md) | [110 d](/filings/0000831259-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,439](/filings/0000831259-23-000037.md) | [1,443](/filings/0000831259-24-000019.md) | [1,442](/filings/0000831259-24-000031.md) | [1,443](/filings/0000831259-24-000039.md) | [1,444](/filings/0000831259-25-000018.md) | [1,445](/filings/0000831259-25-000031.md) | [1,444](/filings/0000831259-25-000050.md) | [1,444](/filings/0000831259-26-000025.md) | [1,443](/filings/0000831259-26-000036.md) | [1,443](/filings/0000831259-25-000050.md) | [1,444](/filings/0000831259-26-000025.md) | [1,443](/filings/0000831259-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,436,017,523 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000831259-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.